BRIMONIDINE TARTRATE and TIMOLOL MALEATE

Pacific Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 24, 2022
Approval ID: 8b13bd5a-b65f-4e39-83f1-8d3abe97d4c0
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE Ophthalmic solution 0.2%/0.5% For topical administration Initial U.S. Approval: 2007

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.